FGF23 and hypophosphatemia: Patients with XLH show local and systemic symptoms, including hypophosphatemia, elevated FGF23 levels, impaired growth, rickets, osteomalacia, bone abnormalities, bone pain, spontaneous dental abscesses, hearing difficulties, enthesopathy, osteoarthritis, and muscular dysfunction27.